Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients

Francisco Esteves1, Jorge Gaspar, Adélcia Tavares

  • 1Unidade de Protozoários Oportunistas/VIH e Outras Protozooses, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal. esteves@ihmt.unl.pt <esteves@ihmt.unl.pt>

Insights

Genetic analysis of Pneumocystis jirovecii in HIV patients identified 48 distinct genotypes. One genotype showed clonal expansion, suggesting successful reproduction and an epidemic population structure for this opportunistic infection.

Area of Science:

  • Medical Mycology
  • Molecular Epidemiology
  • Infectious Diseases

Background:

  • Pneumocystis jirovecii pneumonia (PcP) is a significant opportunistic infection in immunocompromised individuals, particularly those with HIV.
  • Understanding the genetic diversity of P. jirovecii is crucial for tracking its transmission and evolution.

Purpose of the Study:

  • To genetically characterize P. jirovecii strains from HIV-positive patients using multiple genetic loci.
  • To identify associations between P. jirovecii genotypes and patient factors or clinical outcomes.
  • To investigate the population structure and potential clonality within P. jirovecii.

Main Methods:

  • DNA was extracted from P. jirovecii isolates from HIV-positive patients.
  • PCR amplification and sequencing were used to analyze eight distinct genetic loci.
  • Restriction fragment length polymorphism (RFLP) was employed for genotyping.
  • Multilocus genotypes (MLGs) were determined and statistically analyzed.

Main Results:

  • Six loci (mtLSU rRNA, CYB, SOD, beta-tub, DHFR, DHPS) were found to be highly variable and informative.
  • 48 distinct P. jirovecii multilocus genotypes (MLGs) were identified.
  • Significant associations were observed between specific P. jirovecii genotypes and patient age groups or PcP clinical status.
  • One MLG exhibited over-representation, suggesting linkage disequilibrium and clonal propagation, indicative of an epidemic population structure.

Conclusions:

  • The study provides a detailed description of P. jirovecii genetic variability using multiple genomic regions.
  • Genetic profiling of P. jirovecii enhances understanding of its population dynamics and potential for clonal expansion.
  • Findings suggest a complex population structure with evidence of both recombination and clonal reproduction in P. jirovecii.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...